Upload

Loading...

"This is the Bible" - Clip from "Second Opinion: Laetrile At Sloan-Kettering"

2,290

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Feb 19, 2014

Own this film on DVD or Blu-ray or rent or buy it to watch instantly (and get 74 minutes of bonus material): http://www.secondopinionfilm.com/

More info, buy the Blu-Ray, DVD, and the new book and great companion piece to this documentary "Doctored Results" by Ralph W. Moss, PhD:

http://www.secondopinionfilm.com/

About this clip:
Sloan-Kettering's Vice-President Lloyd J. Old, MD discloses to Ralph W. Moss, PhD where he and his peers get all their new ideas for cancer therapies.

About "Second Opinion: Laetrile At Sloan-Kettering":

The War On Cancer, launched in the early 1970s, set the stage for a massive influx of new ideas in fighting the disease of cancer. Memorial Sloan-Kettering Cancer Center, America's leading cancer research center at the time, was assigned the task of testing an unconventional therapy called "Laetrile" in an effort to curb the public's "false hope" in the alleged "quack" therapy.

Ralph W. Moss PhD, a young and eager science writer, was hired by Sloan-Kettering's public relations department in 1974 to help brief the American public on the center's contribution to the War On Cancer. One of his first assignments was to write a biography about Dr. Kanematsu Sugiura, one of the Center's oldest and leading research scientists as well as the original co-inventor of chemotherapy.

While meeting with this iconic scientist to pen a biography on his 60-year career atSloan-Kettering, Moss discovered that Sugiura had been studying this "quack remedy" in laboratory mice, and with unexpectedly positive results. Shocked and bewildered, Moss reported back to his superiors what he had discovered, only to be met with backlash and denial from Sloan-Kettering's leaders on what their own leading scientist had found. 

Fueled by respect and admiration for Sugiura—Ralph W. Moss attempted to publicize the truth about Sugiura's findings. And after all diplomatic approaches failed, Moss lived a double life, working as a loyal employee at Sloan-Kettering while also recruiting fellow employees to help anonymously leak this information to the American public—through a newly formed underground organization they called—"Second Opinion".

Rave reviews from the mainstream media:
Link to all: http://www.secondopinionfilm.com/eric...

“Though a documentary, it’s dramatic enough to be reminiscent of ‘The Insider’, the whistleblowing thriller about Big Tobacco.”
—Graham Fuller, New York Daily News - August 28, 2014

“Mr. Moss’s message is clear, shrewdly edited and peculiarly interesting.”
—Anita Gates, New York Times – August 28, 2014

“an intriguing tale”
—Robert Abele, Los Angeles Times, September 4, 2014

“‘has the production value of a Hollywood whistle-blower thriller”
—The Stranger, Seattle WA, September 18, 2014

“‘Second Opinion’ revives stifled testing of cancer drug”
—San Francisco Chronicle, September 10, 2014

“unraveling the threads of a contested cancer treatment”
—San Francisco Weekly, September 10, 2014

“See this film for a riveting account of the conflicts between corporate power and the public good.”
—Counter Punch – August 29, 2014

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up Next


to add this to Watch Later

Add to

Loading playlists...